Jane Ennis
7Patents
2h-index
5Co-inventors
36Inventor score
Filing activity: Dec 21, 2006 → Mar 13, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8278102B2 | Viable cells from frozen umbilical cord tissue | Human Necessities | 20 | Active |
| US8790923B2 | Viable cells from frozen umbilical cord tissue | Human Necessities | 7 | Active |
| US8309531B2 | Administration of interferon for prophylaxis against or treatment of pathogenic infection | Emerging Cross-Sectional Technologies | 2 | Active |
| US8900573B2 | Immune privileged and modulatory progenitor cells | Chemistry; Metallurgy | 2 | Active |
| US8277794B2 | Immune privileged and modulatory progenitor cells | Chemistry; Metallurgy | 1 | Active |
| US9005599B2 | Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents | Emerging Cross-Sectional Technologies | 0 | Active |
| US9498544B2 | Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.